Japan should follow US efforts to develop new antibiotics

PASTEUR Act addresses growing health crisis of global significance

Avatar
20210708 antibiotics basis.JPG

A labo scientist holds up the basis for new antibiotic: innovative new antimicrobials are desperately needed. © Reuters

Michael W. Hodin is CEO of the Global Coalition on Aging.

New legislation in the United States Congress is usually a routine occurrence, not a seminal event. But the Pioneering Antimicrobial Subscriptions to End Upsurging Resistance, or PASTEUR, Act is different.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.